Rapamycin: A novel immunosuppressive macrolide

This publication has 91 references indexed in Scilit:

• The tyrosine89 residue of yeast FKBP12 is required for rapamycin binding
  Gene, 1993
• A Nonimmunosuppressive Triene-Modified Rapamycin Analog Is a Potent Inhibitor of Peptidyl Prolyl cis-trans-Isomerase
  Biochemical and Biophysical Research Communications, 1993
• A modification of the in vivo mixed lymphocyte reaction and rapamycin's effect in this model
  Clinical Immunology and Immunopathology, 1992
• THE EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON THE REGULATION OF ACTIVATION-INDUCED APOPTOTIC CELL DEATH IN THYMOCYTES
  Transplantation, 1992
• Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells
  Biochemical and Biophysical Research Communications, 1992
• Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice
  Clinical and Experimental Immunology, 1992
• The effect of rapamycin on renal function in the rat: a comparative study with cyclosporine
  Toxicology Letters, 1991
• Incorporation of Acetate, Propionate, and Methionine into Rapamycin by Streptomyces hygroscopicus
  Journal of Natural Products, 1991
• Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
  Proceedings of the National Academy of Sciences, 1990
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
  The Journal of Antibiotics, 1975